Stephen A. Sherwin, Director at NEUROCRINE BIOSCIENCES INC (NBIX), sold 30,000 shares at $118.87 ($3.6M) on 2023-01-03, disclosed to the SEC on 2023-01-05.
Open-market sale of $3.6M NBIX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $118.85 | 15,000 | $1.8M | 50.0% |
| 2 | $118.87 | 15,000 | $1.8M | 50.0% |
| Total | $118.86 avg | 30,000 | $3.6M | 100% |
| Filing → |
| NBIX | SELL | 2025-02-14 | $3.2M | — | Filing → |
| NBIX | SELL | 2024-05-30 | $5.3M | — | Filing → |
| NBIX | SELL | 2022-01-26 | $1.1M | — | Filing → |